Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 5/20 | 0.61 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.61 |
| ▸ | NPY2R | P49146 | 7/20 | 0.60 |
| ▸ | NPY4R | P50391 | 7/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.60 |
| ▸ | NPY1R | P25929 | 5/20 | 0.60 |
| ▸ | TFPI | P10646 | 4/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30495728 | 0.92 | CALCR (0.60) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30804648 | 0.91 | NPY2R (0.63) | CALCRRAMP3NPY2RNPY4RNPY5R | |
| SCHEMBL30495756 | 0.91 | CALCR (0.64) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31182744 | 0.91 | NPY2R (0.67) | CALCRRAMP3NPY2RNPY4RNPY5R | |
| SCHEMBL31182900 | 0.90 | CALCR (0.67) | CALCRRAMP3NPY2RNPY4RNPY5R | |
| SCHEMBL30658338 | 0.90 | CALCR (0.63) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30435977 | 0.90 | CALCR (0.69) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30495665 | 0.90 | CALCR (0.65) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30607412 | 0.90 | CALCR (0.62) | CALCRRAMP3NPY2RNPY4RNPY5R | |
| SCHEMBL30432510 | 0.90 | CALCR (0.60) | CALCRNPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066254-A | Human anti-inflammatory peptides for inhalation treatment of inflammatory lung diseases | 阿德维塔生命科学有限责任公司 | 2022-09-16 | — | — | CN | disclosed |